Why CG Oncology Inc. (CGON) Stock Fell 6.3% on Sep 24, 2026

CG Oncology Inc. moved -5.25% intraday from $73.36 to $69.51. CG Oncology Inc (CGON) stock is down 5.47% today [1.31], trading at $69.35 after closing the previous session at $73.36 [1.31].While there are no negative regulatory or clinical trial announcements directly impacting the company today [1.31], the downward movement is primarily driven by macro-valuation pressures and profit-taking. The stock has experienced a massive year-to-date run of roughly 73% to 76% , touching close to its 52-week high of $80.97 [1.31]. Market analysts recently pointed out that CGON appears fully priced and potentially overvalued on current market multiples. Because the market has already aggressively priced in the success of its bladder cancer pipeline (such as its cretostimogene program), short-term traders are capitalizing on recent gains, putting downward technical pressure on the stock. ## CG Oncology Inc (CGON) $69.34 -5.47% today As of Sep 24, 2:42 PM EDT • Disclaimer 10:00 AM 11:00 AM 12:00 PM 1:00 PM 2:00 PM 70 72 Prev close $73.36 Sep 24, 2026 9:35 AM - 2:42 PM 1D 5D 1M 6M YTD 1Y 5Y Max| Open 73.10 | Mkt cap $6.15B USD | 52-wk high 80.97 | | High 73.44 | P/E ratio- | 52-wk low 35.64 | | Low 68.15 | Div yield- | ### Core Factors Influencing the Downwa

Monitor for follow-through at the close.